Anti-inflammatory activity of a new compound from Vernonia amygdalina

Nat Prod Res. 2021 Dec;35(23):5160-5165. doi: 10.1080/14786419.2020.1788556. Epub 2020 Jul 7.

Abstract

In this study, a new stigmastane, vernonioside V, was isolated from the ethanol extract of leaves of Vernonia amygdalina along with a known flavonoid, cynaroside, and then anti-inflammatory activity of isolated compounds was investigated. The result showed that vernonioside V at concentration of 30 µg/mL strongly inhibited TNFα, IL-6, and IL-8 inflammatory cytokine production. Furthermore, LPS-induced supreoxide generation in Raw 264.7 were significantly reduced by pre-treatment of vernonioside V (30 µg/mL). These data indicated that vernonioside V had inhibitory activities on pro-inflammatory cytokine in LPS-stimulated Raw 264.7 through reactive oxygen species (ROS).

Keywords: Vernonia amygdalina; anti-inflammatory activity; reactive oxygen species; vernonioside V.

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Flavonoids / pharmacology
  • Plant Extracts / pharmacology
  • Plant Leaves
  • Vernonia*

Substances

  • Anti-Inflammatory Agents
  • Flavonoids
  • Plant Extracts